This AACR magazine offers practical knowledge and real hope to cancer patients, survivors, and caregivers.
Abstract Deadline: May 8Present the latest achievements of multidisciplinary research dealing with drug action and resistance.
Deadline: Oct. 12Submit ideas for this grant offering $8 million over three years for innovative projects focused on T-cell lymphoma.
A collection of the most-cited articles published in 2016. Congratulations to the authors for their outstanding work.
Abstract Deadline: April 30Sharing the latest and most exciting developments in lung cancer research
TLR9 Agonist CMP-001-Pembrolizumab Combination Shows Early Efficacy in Patients With Metastatic Melanoma Resistant to Anti-PD-1
Dual Inhibition of IDO1 and PD-L1 Safe in Patients With Advanced Solid Tumors
Short-acting Calcium Channel Blockers Were Associated With Increased Risk of Pancreatic Cancer in Postmenopausal Women
Latest Advances in Lung Cancer Research
Advances in Malignant Lymphoma
AACR-Johnson & Johnson Lung Cancer Innovation Science Grants
Cancer Dormancy and Residual Disease